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Summary
The chromosomal translocation t(7;9)(q34;q34.3) in human T cell acute lymphoblastic leukemia (T-ALL) results in the
aberrant expression of the intracellular domain of Notch (Nic). Consistent with the current multistep model for tumorigenesis,
mice that express Nic in T cell progenitors develop a T-ALL-like disease with a lengthened latency. Proviral insertional
mutagenesis greatly accelerated the onset of leukemia in Nic transgenic mice. We demonstrate that the Ikaros (Ik) locus
is a common target of proviral integration in Nic transgenic mice, which results in the loss of Ik DNA binding activity through
altered isoform expression. We propose that cooperative leukemogenesis occurs in cells that have constitutive Nic and
altered Ik isoform expression because genes normally repressed by Ik become activated by Nic/CSL.
Introduction tion decisions of committed T cell precursors (Wolfer et al.,
2001). One possible explanation for this finding is functional
redundancy among Notch family members. However, there isNotch1 signaling is critically important for cell fate decisions
during hematopoiesis (for review see Allman et al., 2002; Deftos currently no compelling evidence that supports a model for
compensation of Notch1 by related proteins. In contrast, multi-and Bevan, 2000; Kojika and Griffin, 2001; Ohishi et al., 2002).
Several lines of evidence indicate that Notch signaling plays a ple studies using retroviral transduction and transgenics have
provided evidence indicating that Notch1 signaling does havedirect role during many of the bifurcation points during hemato-
poiesis, including the transition of a common lymphoid progeni- an active role in T cell maturation. Transgenic mice that express
alleles of Nic in immature T cells have an accumulation of eithertor cell to a mature T cell. Expression of constitutively active
Notch1 (Nic) in bone marrow (BM) hematopoietic stem cells CD8 SP T cells or both CD4 and CD8 SP mature T cells
(Deftos et al., 2000; Robey et al., 1996). Additionally, infection(HSC) not only directs lineage commitment toward T cells in a
thymus-independent manner, but also blocks the development of bone marrow cells with virus expressing Nic impairs the matu-
ration of immature CD4/CD8 double positive to SP T cellsof B cells (Pui et al., 1999). In addition, targeted disruption of
Notch using an interferon inducible cre/lox system in postnatal when the infected cells are used to reconstitute lethally irradi-
ated mice (Izon et al., 2001). Moreover, it has been suggestedmice results in the early arrest of T cells and causes an accumu-
lation of immature B cells in the thymus (Radtke et al., 1999). that Notch1 is able to inhibit TCR-induced apoptosis of CD4/
CD8 DP T cells by interaction with, and inhibition of, Nurr77In addition, expression of Lunatic Fringe, which is a negative
regulator of Notch signaling, in thymic progenitors also leads (Jehn et al., 1999). This data could, at least in part, explain
the accumulation of T cells observed in each of these cases.to an accumulation of B cells in the thymus (Koch et al., 2001).
These data indicate that Notch functions, in part, to direct T cell Therefore, it appears that a lack of Notch1 signaling does not
alter the maturation of committed T cells, but constitutivecommitment by suppressing B cell differentiation. However, the
role of Notch signaling in cells that have committed to a T cell Notch1 signaling does perturb the maturation of T cells by di-
recting cells to adopt one fate over another.fate is, at this point, not completely understood. Targeted dis-
ruption of the Notch1 gene in immature (CD25CD44) T cell The mammalian Notch gene family consists of four closely
related members (Notch1–4). Substantial evidence now existsprecursors did not effect the maturation of these cells to become
either a CD4 or a CD8 single positive (SP) T cell, providing that Notch1, Notch2, and Notch3 play direct roles in leukemo-
genesis (Aster and Pear, 2001; Aster et al., 2000; Bellavia et al.,data that active Notch1 signaling is not required in the matura-
S I G N I F I C A N C E
Elucidation of the cooperative networks involved in leukemogenesis will have significant impact on the treatment of disease by
providing multiple targets for drug intervention and prognostic markers. Here we provide evidence that mutations in Notch and Ik
cooperate in leukemogenesis in mice and, perhaps, humans. Ik is commonly mutated in pediatric B- and T-ALLs; however, the
t(7;9)(q34;q34.3) translocation is a rare event. Interestingly, we observed that in a human T-ALL cell line that harbors an Ik mutation,
there was constitutively nuclear Nic, suggesting that the role of Notch in leukemia should be addressed independently from the
translocation. Future clinical studies will be useful in determining the precise link between mutations in Ik and activated Notch in
human leukemia.
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2002; Ellisen et al., 1991; Pear et al., 1996; Rohn et al., 1996). zinc fingers critical for DNA binding. Mice that are heterozygous
for a DI isoform of Ik develop aggressive T cell leukemia (Wi-The Notch1 locus was found to be involved in the chromosomal
nandy et al., 1995). Moreover, in a majority of human pediatrictranslocation t(7;9)(q34;q34.3) in cells (SUP-T1) derived from a
T- and B-ALL patients, DI isoforms are overexpressed (Sun ethuman T cell acute lymphoblastic leukemia (T-ALL) (Ellisen et
al., 1999a, 1999b, 1999c). The spontaneous appearance of DIal., 1991). In this translocation, the sequences encoding most of
isoforms in leukemia patients in conjunction with the DI trans-the extracellular domain of Notch1 are replaced with sequences
genic mouse data suggests that inhibition of normal Ik functionderived from the T cell receptor  locus. This results in the
may be a common event in the progression of human leukemia/aberrant expression of Notch1 proteins truncated of almost the
lymphoma.entire extracellular domain and, therefore, constitutively active
Using proviral insertional mutagenesis we have identifiedsignaling by Nic-like molecules. Reconstitution of lethally irradi-
the Ik locus as a common target of proviral integration in 40%ated mice with BM cells expressing analogous Nic constructs
of tumors arising in Nic transgenic mice that were infected withresulted in the development of T cell leukemia, indicating that
Moloney murine leukemia virus. We demonstrate that Ik andaberrant Nic expression predisposes mice to T cell leukemia,
the Notch effector protein CSL are able to bind the same con-and therefore recapitulates some aspects of the human disease
sensus core DNA sequence in vitro. Using a reporter containing(Aster et al., 2000; Pear et al., 1996). Aberrant expression of
multiple copies of this consensus core sequence, we also dem-other Notch family members has also been implicated in leuke-
onstrate that Ik can inhibit the CSL-dependent transcriptionalmogenesis. For example, infection of cats with replication com-
activity of Nic. We propose a model in which regulatory se-petent feline leukemia virus (FeLV) yielded T cell lymphoma that
quences normally occupied by Ik become unoccupied throughharbored recombinant FeLV that had transduced a portion of
loss of Ik DNA binding activity, therefore allowing access tothe Notch2 gene (Rohn et al., 1996). Furthermore, forced expres-
CSL. As a consequence, in cells that have constitutive Nic andsion of Notch3ic in T cells under control of the lck promoter
altered Ik isoform expression, genes normally repressed by Ikresulted in aggressive T cell leukemia/lymphoma in transgenic
can be activated by Nic/CSL. Furthermore, we demonstrate thatmice (Bellavia et al., 2002).
a cell line derived from a patient with DI Ik isoforms expressesNotch signaling is initiated upon direct interaction between
activated Notch protein in the nucleus, indicating that mutationNotch and a DSL ligand presented on an adjacent cell (Kidd et
of these two genes may be a common event in leukemogenesis.al., 1989; Muskavitch, 1994; Nye and Kopan, 1995; Tax et al.,
1994; Wharton et al., 1985; Bray and Furriols, 2001; Mumm and
ResultsKopan, 2000). This interaction results in proteolytic processing
that releases Nic from the plasma membrane. Subsequently, Nic
Infection of neonatal lck-Nic mice with MLV acceleratestranslocates to the nucleus, where it interacts directly with the
the onset of T cell leukemiaDNA binding protein CSL and the coactivator protein Master-
Transgenic mice that constitutively express Nic under the T cell-mind-like1 (maml-1) to activate transcription of target genes
specific lck proximal promoter were used as a model for Nic(Jeffries et al., 2002; Kitagawa et al., 2001; Wu et al., 2000). In
induced T cell leukemia (Robey et al., 1996). lck-Nic transgenicaddition, there is evidence that suggests that other proteins
mice develop T cell leukemia at a frequency of approximatelymight be associated with Notch, CSL, and maml-1 in this activa-
20% by five months of age (see Supplemental Data at http://tor complex (Jeffries et al., 2002; Oswald et al., 2001; Wallberg
www.cancercell.org/cgi/content/full/3/6/551/DC1). To identifyet al., 2002). Although the exact mechanism by which Nic drives
genes important in the development of Nic-induced leukemia, wetumorigenesis is not entirely understood, it is clear that Notch
used proviral insertional mutagenesis. Neonatal Nic transgenic
must accumulate in the nucleus and incorporate into the activa-
mice and nontransgenic littermates were infected intraperitone-
tor complex (Jeffries and Capobianco, 2000; Jeffries et al., 2002; ally with tissue culture supernatants containing Moloney murine
Ronchini and Capobianco, 2000). Mutations in Nic that disrupt leukemia virus (MLV). Nontransgenic littermate control mice that
complex formation also fail to activate transcription of targets were infected with MLV developed leukemia at an approximate
genes, such as cyclin D1 (Ronchini and Capobianco, 2001). frequency of 50% by 6 months of age. In contrast, infection of
Furthermore, growth of SUP-T1 cells is inhibited by disrupting Nic transgenic mice with MLV (N/MLV) increased the penetrance
the complex using dominant negative alleles of maml-1 encod- of leukemia to 100% and decreased the latency to 2 months
ing only the sequences encompassing the Notch binding do- of age (see Supplemental Data). These data indicate that proviral
main (Weng et al., 2003). Taken together, this data indicates integration is acting as a cooperative event for leukemogenesis
that the integrity of this complex is absolutely critical for Nic in Nic transgenic mice. To demonstrate that N/MLV tumors har-
transforming activity. bored novel ectopic proviral integrations, DNA was extracted
Ikaros (Ik) is a transcriptional regulator that is critically impor- from tumors and analyzed by Southern blot analysis using a
tant in the development of all lymphoid-derived cells (Georgo- portion of the env and LTR proviral sequences (Figure 1A; probe:
poulos et al., 1994; Wang et al., 1996). Ik is expressed as multiple E/S). In all samples, including the noninfected, nontransgenic
isoforms that arise from differential splicing. All reported iso- normal spleen (ni), the E/S probe detected a band at approxi-
forms contain two protein dimerization zinc fingers, but have a mately 3 kb that corresponds to endogenous proviral se-
variable number of DNA binding zinc fingers (Hahm et al., 1994; quences. However, the tumor samples harbored multiple novel
Molnar and Georgopoulos, 1994). Ik isoforms that do not contain integrations of the ectopic MLV provirus in the genome. To
the internal DNA binding zinc fingers are able to dimerize with assess if the tumor samples were clonal in origin, Southern blots
DNA binding isoforms of Ik and behave as dominant inhibitors were probed using a portion of the TCR locus (Figure 1B).
(DI) of Ik DNA binding activity (Sun et al., 1996). A role for DI Previous work by others has shown that the Notch gene
isoforms in tumorigenesis has been established in a mouse locus is a common site of proviral integration in transgenic mice
infected with MLV (Feldman et al., 2000; Girard et al., 1996;model by using targeted disruption of the Ik exons encoding
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Figure 1. Southern blot analysis of N/MLV accelerated lymphomas
A: Genomic DNA was extracted from spleen samples of leukemic N/MLV mice and one nontransgenic, noninfected mouse (ni). Genomic DNA was
digested with BglII and subjected to Southern blot analysis using the E/S probe (top). The arrow indicates the endogenous proviral sequences detected
by the E/S probe. Molecular weight markers are indicated at the left in kilobase pairs (kb). The bottom panel illustrates the location of the BglII restriction
site within the proviral env sequences, as well as the region of the provirus used for the probe (E/S).
B: Genomic DNA from the samples was digested with EcoRI and subjected to Southern blot analysis using a portion of the TCR locus. The arrow indicates
the unrearranged TCR locus.
C: Genomic DNA was digested with EcoRI and Southern blot analysis was performed using c-myc2.3 probe (top). The open arrow indicates the potential
integration in the c-myc locus. The solid arrow indicates the normal c-myc allele.
D: Genomic DNA was digested with EcoRI and Southern blot analysis was performed using the IPCR clone V128 as a probe. A band corresponding to the
endogenous locus migrates just below the 5 kb marker. Open arrows indicate loci rearranged due to introduction of proviral sequences. *, integrations
identified by Southern blot, #, integration identified by directed PCR.
E: A schematic representation of the 5 kb EcoRI fragment is shown illustrating integrations and viral LTR/genomic junctions.
Hoemann et al., 2000; Kim et al., 2003; Lund et al., 2002; Mikkers commonly targeted by proviral integration in c-myc/MLV tu-
mors, only one of the N/MLV tumors appeared to harbor anet al., 2002). In fact, it has been reported that the Notch locus
integration in the c-myc locus (Figure 1C). These results indicateis targeted by MLV integration in more than 50% of c-myc-
that, although MLV infection of Nic transgenic mice is a coopera-induced MLV leukemias (Girard et al., 1996). This data indicates
tive event that accelerates leukemogenesis, it is not likely duethat misregulation of the Notch gene may be an important event
to integration and disruption of the c-myc locus.in leukemogenesis with overexpressed c-myc as the first genetic
alteration. To determine if the c-myc locus is a common target
of proviral integration in N/MLV tumors, we performed Southern Identification of a common site of proviral integration
blot analysis on tumors using a probe specific for exons 2 and In order to determine what gene(s) might be important for the
rapid onset of leukemia in N/MLV mice, we sought to identify3 of c-myc. In contrast to the finding that the Notch locus is
CANCER CELL : JUNE 2003 553
A R T I C L E
Figure 2. MLV integration into the Ik locus disrupts normal Ik expression
A. The Ik locus is illustrated to show the relative positions of the exons and the size of the locus. Arrows above the diagram represent the cluster of integrations
identified in the intron between exon 2 and exon 3. DNA binding, isoforms capable of binding DNA. Non-DNA binding, naturally occurring isoforms not
capable of binding DNA. LAI, leukemia associated isoforms identified herein. Deletions in exon 4 and 6 are illustrated by the dashed lines, amino acid
numbering corresponds to Ik-1.
B: rt-PCR analysis was performed on RNA from a panel of tumor samples using primers specific for exons 1 and exon 7 of Ik. *, integration found by Southern
blot, #, integrations identified by directed PCR. rt-PCR using -actin primers is shown on the bottom for loading control (actin).
C: Western blot analysis on whole cell lysates from the same panel of tumor samples (B) shows the overexpression of DI Ik isoforms in samples with a skew
in isoform expression (B). A Western blot for tubulin is shown from the same lysates as a loading control (Tub).
common sites of proviral integration. We used inverse PCR Proviral integration into the Ik locus leads to aberrant
isoform selection(IPCR) as a high-throughput method for cloning proviral integra-
tion tags (pvits). IPCR-derived clones were sequenced and sub- Since previous work has demonstrated that DI isoforms of Ik
can induce T cell leukemia, we were interested in determiningsequently analyzed using the NCBI blast database. Individual
pvits were then used to screen slot blots of BAC clones obtained which Ik isoforms were produced in N/MLV tumors (Winandy
et al., 1995). RNA from a panel of N/MLV tumors was analyzedfrom the BAC library screen. DNA probes made from pvits V128
and V178, obtained from tumor samples 18 and 47 respectively, for expression of Ik mRNA by rt-PCR (Figure 2B). Spleen tissue
from a noninfected, nontransgenic (ni) mouse contained pre-hybridized to the same BAC clone (1653 443-L7). To determine
the frequency of proviral integration into this locus, we per- dominantly Ik-1 and Ik-2 (Ik-1/2) message. Samples from MLV
infected Nic transgenic mice that do not harbor a proviral integra-formed Southern blot analysis on tumor samples using the V128
probe (Figure 1D). The V128 probe detected a band that mi- tion in the Ik locus also predominantly express Ik-1/2. However,
tumor samples from MLV infected Nic mice that harbor proviralgrated at approximately 5 kb in all samples, including the sample
obtained from a noninfected, nontransgenic mouse (ni). As ex- integration in the Ik locus displayed Ik mRNA expression that
was altered in one of two ways. The first consequence of integra-pected, the V128 probe detected bands in samples 18 and 47
that migrated with altered mobility due to the introduction of tion in the Ik locus was a dramatic reduction in total Ik-1/2
message (Figure 2B, lanes 14, 32, 47, 50). The second is thatan EcoRI restriction site that is present in the provirus (Figures
1D and 1E). Interestingly, five other samples also contained some of the tumors with integrations in the Ik locus had a skew
in isoform selection, which led to the expression of the smallerbands that migrated with altered mobilities. Directed PCR clon-
ing was performed using MLV-specific primers and primers DI isoforms of Ik (Figure 2B, lanes 24, 40, 46). We cloned the rt-
PCR products from these samples (as described in Experimentaldesigned from the 5 kb EcoRI locus to determine LTR/genomic
DNA boundaries of the proviral integrations (Figure 1E). Using Procedures) and sequenced the resulting clones to determine
if mRNA products corresponded to previously identified iso-this technique, we demonstrated that samples 32, 40, and 46
also harbored proviral integrations that were located just up- forms. A number of previously identified DI isoforms were cloned
from the N/MLV tumors, as well as a number of uncharacterizedstream of the EcoRI restriction fragment (V411 and V412). There-
fore, at least 40% of tumors analyzed contain proviral integration isoforms, which we collectively termed leukemia associated iso-
forms (LAI) (Figure 2A). Three of these isoforms have exon con-into the V128 locus. Sequence analysis of the locus using the
Celera database showed that the V128 locus is contained within figurations that have not been described previously (9, 10170–197,
1170-197). Ik-9 encodes all exons except exon 4, which encodesa 50 kb intron between exon 2 and exon 3 of the Ik gene (Figure
2A). This is the first demonstration that Ik is a common target the critical DNA binding zinc fingers. Ik-10170–197 does not en-
code exon 5 and has a deletion in exon 4 (amino acids 170–194)of proviral integration, and indicates that integration into the Ik
gene is a specific cooperative event with Nic. that results in the loss of the second DNA binding zinc finger.
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This deletion was also identified in the context of full length Ik-1
(1170–197). Two other LAI cloned from the N/MLV tumors have
been previously described and cloned from pediatric T-ALL
patients (Sun et al., 1999a, 1999b). These isoforms contain a
10 amino acid deletion corresponding to the last 30 base pairs
of exon 6 (Ik-7275–284 and Ik-8275–284). All LAI are predicted not
to bind DNA, and therefore should behave as DI isoforms, due
to disruption or lack of residues critical for DNA binding. Tumor
39 displayed altered Ik isoform expression; however, we could
not conclusively determine that there was an integration in the
Ik locus by Southern blot analysis or directed PCR. It is possible
that we were unable to detect an integration because it is out
of the relatively small region that we are examining (3 kb)
within the 50 kb intron. To determine if the Ik mRNA profile
of the N/MLV tumors correlated with protein expression, we
performed Western blot analysis on the same panel of tumor
samples using a polyclonal antibody (anti-IK) generated against
Ik-6 that recognizes exons 1, 2, and 7 (found in all known iso-
forms of Ik) (Figure 2C). Samples that had an increase in mRNA
levels of the DI isoforms by rt-PCR analysis also displayed
increased levels of DI Ik proteins. In contrast, there were no
detectable Ik proteins in either noninfected, nontransgenic (ni)
spleen tissue or the tumor samples that display a decrease in
Ik message. We observed a band approximately the size of Ik-1
in tumor 36, however, as in tumor 39 we have not been able
to conclusively determine that there is an integration into the
Ik locus in this tumor. Since this sample has a relatively normal
Ik mRNA expression pattern, compared to the ni sample, we
predict that this sample might also contain the LAI Ik-1170–197.
These data indicate that MLV integration into the Ik locus results
in a perturbation of Ik expression and isoform selection.
Figure 3. MLV integration into the Ik locus is specific for the Nic transgenicTo determine that the effects seen on the expression pattern
background
of the Ik gene are due specifically to MLV integration in the Ik
A: Southern blot analysis was performed using the E/S probe on genomiclocus, we generated a number of tumors from non-Nic transgenic
DNA obtained from non-Nic transgenic mice infected with MLV (samples
mice that were infected with MLV (MLV tumors). These tumors 1–13). The arrow indicates the endogenous proviral sequences recognized
displayed multiple ectopic proviral integrations, similar to the by the E/S probe.
B: The V128 probe was used for Southern blot analysis on the MLV tumorN/MLV tumors (Figure 3A). However, unlike the N/MLV tumors,
samples (samples 1–13). Samples from both the MLV tumors and N/MLVnone of the MLV tumors harbored integration in the Ik locus
tumors were analyzed with the V128 probe to demonstrate that non-Nic
(Figure 3B, non-Nic samples 1–13 compared to Nic samples). transgenic mice do not harbor integration into the Ik locus.
Furthermore, analysis of Ik mRNA from MLV tumors revealed C: rt-PCR analysis of RNA extracted from the MLV tumors was performed
as described for B. To demonstrate the analysis was performed in the linearthat expression from the Ik locus was normal compared to
range, the ni cDNA was diluted in half (ni-0.5) before rt-PCR was carriednoninfected (ni) spleen tissue (Figure 3C). These data indicate
out. All samples contain comparable levels and isoforms of Ik (Ik). -actinthat proviral integration into the Ik locus is a specific event for
was used to normalize the amounts of cDNA used in each reaction (actin).
the Nic transgenic background and integration into the Ik locus
causes an alteration in Ik expression. Futhermore, these data
support the prediction that tumors 36 and 39 likely contain
integrations into the Ik locus. fusion proteins of CSL, Ik-1, and Ik-6 were assayed for the
ability to bind the IK-BS2 oligo (Figure 4B). Ik-1 and CSL were
Ik and CSL recognize a similar core DNA consensus capable of binding to the IK-BS2 oligo with similar affinity. Ik-6,
sequence, TGGGAA however, did not bind the IK-BS2 oligo. The interactions of Ik-1
Examination of the consensus DNA binding sequence for Ik and and CSL with the IK-BS2 oligo were specific, as they were able
CSL revealed that both proteins recognize the core sequence to be competed with 100-fold molar excess of the unlabeled wt
TGGGAA (Figure 4A). Therefore, we formulated the hypothesis oligo (TGGGAA), but not with 100-fold molar excess of unlabeled
that Ik and CSL might compete for the same regulatory elements mutant oligo (TGAGAA for Ik-1 and CTGGAA for CSL). More-
within promoters of certain genes and differentially regulate over, a single base pair mutation in the consensus sequence
transcription. To demonstrate that both Ik and CSL are capable of the IK-BS2 oligo (TGAGAA) abrogated Ik-1 binding but only
of binding the same consensus DNA sequences, we performed moderately affected the binding of CSL to the oligo. The ability
electrophoretic mobility shift assays (EMSA) using an oligo that of CSL to bind the mutant oligo indicates that contact sites for
contains the consensus core sequence TGGGAA (IK-BS2) and CSL and Ik may differ and that there might be sites that can
has been previously shown to be a binding site for Ik (Molnar be bound exclusively by CSL. A similar experiment was per-
formed to determine if any of the Ik LAI were capable of bindingand Georgopoulos, 1994). Glutathione-agarose purified GST
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Figure 4. Ik and CSL bind the same consensus DNA sequence, TGGGAA
A: Sequences previously described that bind either Ik or CSL. Ik, sequences that Ik has been shown to specifically bind; CSL, sequences that only CSL has
been shown to bind; Ik/CSL, sequences that we found both proteins are capable of binding. The column to the right of the sequences summarizes the
experimental binding data. , binding; , no binding; nd/, binding was not examined experimentally, but is predicted not to bind. Abbreviations for
genes are as follows: CD3, CD3-T cell receptor complex component; MCFV U3, mink cell focus virus U3 portion of the LTR; TDT, terminal deoxynucleotidyltrans-
ferase gene; pre TCR, component of the pre-T cell receptor complex; IL-2R, interlukin-2 receptor subunit.
B: DNA binding experiments were performed using the oligo IK-BS2, originally described as an Ik binding site containing the consensus sequence TGGGAA.
GST fusion proteins of Ik-1 (Ik-1), Ik-6 (Ik-6), and CSL were produced and purified as described in the Experimental Procedures. Probes correspond to: w, wt
oligo containing the consensus TGGGAA; m, mutant oligo containing single base mutation to TGAGAA. For competition experiments (comp), 100-fold
molar excess of cold oligo was used. Since CSL is capable of binding both the mutant and wild-type IK-BS2 oligo, competition was carried out with oligos
that contain either three copies of the the wild-type TGGGAA (3 wt) or mutant site CTGGAA (3 mut).
C: EMSA analysis was performed using the IK-BS2 wt oligo with the LAI cloned from the N/MLV tumors. Lane numbers correspond to the Ik isoforms illustrated
in Figure 2A. The bottom panel displays the relative amount of each protein used in each binding reaction as determined by Western blot analysis using
an anti-Ik antibody.
D: EMSA experiments were performed as described for Figure 5B using an oligo designed from the IL2r- promoter sequence. Probes: w, oligo derived from
IL2r- promoter; m, single base pair mutation to TGAGAA.
to IK-BS2 under the same conditions (Figure 4C, upper panel). genes for exact matches to the six base pair consensus core.
We found that the IL-2 receptor  (IL2R-) contains a perfectIk-1 and Ik-2 bound the oligo with similar affinity. However, no
protein/DNA complexes were observed with either GST or any match to the consensus sequence TGGGAA located 1512 nu-
cleotides upstream from the start site of transcription (Codiasof the LAI tested. Western blot analysis was performed on pro-
teins to show relative amounts of each isoform used for the et al., 2000). Oligos that encompass this sequence, including
ten nucleotides specific to the IL2R- promoter on either side,DNA binding experiments (Figure 4C, lower panel). This data
indicates that the isoforms produced in the N/MLV tumors are were designed. As before, a single base pair mutation of the
core sequence to TGAGAA was also designed. EMSA analysisnot capable of binding DNA and are therefore likely to behave
as DI isoforms. To further investigate if there are any sites in using these oligos demonstrated that Ik-1, Ik-2, and CSL bound
the sequence derived from the IL2R- promoter (Figure 4D).physiological promoters that Ik and CSL might be able to bind
and regulate, we scanned promoter sequences of T cell specific Only CSL exhibited the ability to bind the oligo with the single
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base pair mutation, but with a decreased affinity. No DNA/
protein complexes were detected in the GST or Ik-6 lanes,
supporting the model that Ik-6 does not bind DNA and could
act as a DI Ik isoform sequestering the DNA binding isoforms
through heterodimer formation. We also identified a number of
promoters in the literature that either CSL or Ik have been re-
ported to bind individually, as well as the sequences used herein
that both proteins are capable of binding (Figure 4A) (DiFronzo
et al., 2002; Georgopoulos et al., 1992; Hu et al., 2001; Jarriault
et al., 1995; Lam and Bresnick, 1998; Reizis and Leder, 2002;
Ronchini and Capobianco, 2001; Trinh et al., 2001). We per-
formed EMSA analysis with a number of oligos designed on the
basis of these sequences to test if Ik and/or CSL were capable
of binding them in vitro. We found that although the core
TGGGAA may be the preferred binding sequence for each of
these proteins, it may not, in some cases, be sufficient. More-
over, Ik appears to have a more stringent requirement for the
base pairs that flank the core sequences, as displayed by its
inability to bind some of the indicated oligos, consistent with a
previous report by the Georgopoulos group (Molnar et al., 1996).
These data indicate that Ik and CSL are capable of binding
similar core DNA consensus sequences and, therefore, may
differentially regulate the transcription of target genes containing
these overlapping regulatory elements in their promoters.
Ik-1 blocks CSL-dependent Nic
transcriptional activation
Ik and CSL have both been shown to function as sequence-
specific DNA binding transcriptional regulators. Since we have
demonstrated that both proteins are capable of binding the
same DNA sequence, we wanted to determine if Ik had any Figure 5. Ik-1 represses Nic activity in vitro and coexpression of Ik-6 relieves
effect on Nic-induced transcriptional activation. To determine this repression
the functional consequence of the competition between Ik-1 and A: A luciferase reporter assay was performed using a reporter that contains
eight copies of the consensus sequence TGGGAA. Relative activity is basedCSL, we performed luciferase reporter assays using a reporter
on activation of the reporter by Nic and is set to 1 (lane 2). Empty vectorconstruct that contains eight tandem copies of a sequence
(v, lane 1) shows basal level of activation from the reporter. Increasingcontaining the core consensus TGGGAA. This reporter has pre- amounts of Ik-1 represses the transcriptional activation in the presence of
viously been used to measure CSL-dependent Nic transcrip- constant Nic (lanes 3–5), while increasing amounts of Ik-6 do not repress Nic
tional activity (Fuentes-Panana and Ling, 1998; Jeffries and activity (lanes 7–9). Ik-1 (lane 6) or Ik-6 (lane 10) alone do not activate the
reporter over the level of empty vector. The total amount of DNA in eachCapobianco, 2000). Nic activated the reporter construct twelve-
lane is held constant by addition of empty vector. Experiments were per-fold compared to vector, whereas expression of Ik-1 or Ik-6 did
formed at least twice. Error bars represent the standard deviation of a
not activate the reporter (Figure 5A). However, when increasing representative experiment performed in triplicate.
amounts of Ik-1 were cotransfected with Nic, the reporter activity B: Luciferase reporter assays were performed using the same reporter used
in Figure 6A. Nic activity is repressed by Ik-1 (lane 3). Cells were transfecteddecreased in a dose-dependent manner to levels comparable
with 100 ng of Nic and Ik-1 with an increasing amount of Ik-6 (100 ng–600to vector alone. In contrast, cotransfection of Nic with increasing
ng, lanes 4–6) or GFP (100 ng–600 ng, lanes 7–9).amounts of Ik-6 had no effect on activation of the reporter by
Nic. These results indicate that Ik competes for binding to the
CSL sites and blocks transcriptional activation by Nic.
Several of the N/MLV tumor samples displayed a skew in CSL-dependent Nic transcriptional activation at sequences that
Ik isoform expression that led to an increased level of the DI were previously occupied and repressed by Ik-1.
isoforms expression. To determine if overexpression of DI Ik-6
is able to inhibit Ik-1 repressive activity, we cotransfected in- Human leukemia cells with DI Ik and activated Nic
creasing amounts of Ik-6 in the presence of constant Nic and We have previously shown that activated Nic is localized to the
Ik-1. As before, Nic alone activated the reporter and cotransfec- nucleus and is part of a high molecular weight multiprotein
tion of Nic with an equal amount of Ik-1 blocked this activity. complex in both RKE cells and the T-ALL derived cell line, SUP-
However, when Ik-6 was cotransfected with Nic and Ik-1, we T1 (Jeffries et al., 2002). Both nuclear localization and complex
observed a dose-dependent relief of Ik-1 repression of the re- formation appear to be strict requirements for Nic transforming
porter, whereas increasing amounts of GFP had no effect (Figure activity (Jeffries and Capobianco, 2000; Jeffries et al., 2002;
5B). These experiments demonstrate that Ik-1 is able to block Ronchini and Capobianco, 2000). To determine if there is a
the transcriptional activity of Nic on a CSL-dependent reporter, link in human leukemia between DI Ik and activated Notch, we
and this transcriptional block can be relieved by expression of examined several leukemic cell lines for evidence of activated
Notch. The Molt-3 cell line has been reported to express DI Ik,DI Ik (Ik-6). Therefore, the loss of Ik-1 DNA binding activity allows
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tected in the Molt-3 cells is associated in a large molecular
weight complex, 2 mg of each nuclear extract was separated
on a Superose-6 gel filtration column (Figure 6B). Nic migrated
with a peak of immunoreactivity at fraction 30, similar to that
observed for SUP-T1 cells (Figure 6B and Jeffries et al., 2002).
However, Jurkat cells contained only very faint bands that
peaked in fraction 31, but migrate at a size larger than that of
Nic and may represent a precursor form of Notch, probably due
to membrane contamination of the nuclear fraction. Neverthe-
less, these data provide evidence that disruption of normal Ik
gene expression, in conjunction with activated Notch, is a com-
mon event in leukemogenesis in N/MLV induced mouse tumors,
and might also be in spontaneous human neoplasms.
Expression Nic and Ik-6 in bone marrow cells leads
to more aggressive T cell lymphoma
To directly assess if coexpression of Nic and Ik-6 cooperates in
T cell leukemogenesis, we performed bone marrow reconstitu-
tion assays. Bone marrow (BM) cells were isolated from pre-
treated 5-Flourouracil Top-Notch transgenic mice. Top-Notch
mice express Nic under the control of the tetracycline operator
sequences. Isolated BM was either infected with bicistronic
retroviruses expressing the tetracycline transactivator (tTA) and
Ik-6 (MIT-I6) or the tTA alone (MIT-RX). Infection with these
viruses leads to inducible expression of the Nic transgene in the
absence of doxycycline (dox), whereas addition of dox in the
drinking water silences expression of Nic. Following infection,Figure 6. A cell line derived from human T cell leukemia expresses DI Ik and
activated Notch BM was transplanted into lethally irradiated syngeneic mice.
A: Nuclear extracts from MOLT-3 and SUP-T1 cells contain large amounts of Cohorts of mice were either treated with doxycycline to inhibit
Nic. Nuclear lysate from each cell line was immunoprecipitated using the activation of the Nic transgene or not treated. Eight weeks follow-
Notch polyclonal antibody, 927, followed by Western blot analysis using the ing transplantation, mice that were reconstituted with BM ex-
Notch monoclonal antibody 15A (top panel). Western blot analysis nuclear
pressing Nic and Ik-6 were moribund with visible signs of lym-lysate from each cell line was performed with an anti-CDK4 antibody to
phoma, whereas mice reconstituted with BM expressing Nicshow equal amount of protein in the lysates.
B: 2 mg of nuclear lysate from each cell line was separated on a superpose alone displayed only mild signs of disease and were diagnosed
6 gel filtration column using FPLC. Column fractions were TCA precipitated with lymphoma due to a palpable spleen. Control mice displayed
and analyzed by Western blot using anti-Notch 927 antibody. i represents
no visible signs of lymphoma. Mice were euthanized and visually5% of the total input loaded onto the column, and the lane numbers corre-
examined for internal distress caused by lymphoma. Single cellspond to the fractions collected. * indicates the Molt-3 profile Western blot
was exposed half the time as compared to the SUP-T1 or Jurkat Western suspensions were prepared from the spleens of all animals and
blot. Approximate molecular weight is indicated on the right in kDa and analyzed by FACS analysis for CD4 and CD8. Control mice
arrows indicate the size at which Nic migrates. The arrowhead above fraction expressing neither Nic nor Ik-6, as well as mice expressing only
34 indicates the migration of the size standard, thyroglobulin (669 kDa).
Ik-6, appeared normal by both FACS analysis and visual autopsy
(Figure 7A). Mice expressing Nic had a grossly enlarged spleen
that was populated by immature CD4/CD8 double positive
T cells, characteristic of leukemia. In contrast, mice expressingbut has no known mutation in Notch (Sun et al., 1999a, 1999b).
Nic and Ik-6 appeared to have lymphoma that was much moreSUP-T1 cells harbor the t(7;9)(q34;q34.3) translocation involving
aggressive by both FACS analysis and autopsy (Figure 7A).Notch1, but have unknown Ik status (Ellisen et al., 1991). Jurkat
These mice displayed involvement of lymph nodes, thymus,cells have been shown to express apparently normal Notch and
spleen, and liver. Cells isolated from the spleen were almostIk (Aster et al., 1994; Sun et al., 1999a). To determine if these cell
exclusively CD4/CD8 double positive (Figure 7A). Primarylines expressed activated Notch in the nucleus, we performed
leukemic cells (5  105) were then transplanted from these micesubcellular fractionation. Equal amounts of nuclear proteins
into the tail vein of syngeneic FVB/n mice and monitored untilfrom each cell line were immunoprecipitated with an affinity
moribund. Leukemic cells that express both Nic and Ik-6 werepurified Notch polyclonal antibody (927) followed by Western
much more aggressive in the development of leukemia, withblot analysis using the Notch monoclonal antibody 15A (Figure
nearly 3-fold decrease in the mean latency of terminal disease6A, top panel). Similar amounts of Nic were detected in the
compared to cells that express Nic alone, 24 days compared tonucleus of both Molt-3 and SUP-T1 cells, indicating that Molt-3
64 days (Figure 7B). Cells that did not express Nic did not leadcells have constitutively activated Notch in the nucleus. In con-
to the development of leukemia. These data demonstrate thattrast, no detectable Notch protein was immunoprecipitated from
Nic and Ik-6 cooperate in leukemogenesis. Furthermore, theythe Jurkat nuclear fractions. For normalization of the nuclear
demonstrate that sustained Notch activity is required for mainte-lysates, we determined the expression of CDK4 and found that
nance of the leukemic phenotype even in the presence of aall three cell lines expressed equal levels in the nuclear lysates
(Figure 6A, bottom panel). To assess if the nuclear Notch de- cooperating mutation.
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Figure 7. Nic and Ik-6 directly cooperate in T cell
leukemia
A: Visual autopsy and FACS analysis of mice eight
weeks following bone marrow reconstitution.
Mice were reconstituted with BM expressing no
protein (MIT-RX, dox), Ik-6 alone (MIT-I6, dox),
Nic alone (MIT-RX, dox), or both Ik-6 and Nic
(MIT-I6, dox). Mice receiving BM expressing Nic
alone display early signs of leukemia, including
enlarged spleen and an increase in CD4/
CD8 T cells in the spleen. Mice receiving cells
expressing both Ik-6 and Nic display signs of a
much more aggressive leukemia, including en-
largement of spleen, lymph nodes, liver, and thy-
mus, as well as complete effacement of the
spleen by immature CD4/CD8 T cells.
B: Transplantation of primary leukemias express-
ing Nic and Ik-6 leads to a marked decrease in
survival of transplant recipients. Single cell sus-
pensions of leukemia were prepared from the
spleen of MIT-RX, dox mice or MIT-I6, dox
mice. Cells were then transplanted into the tail
vein of syngeneic mice and assayed for the de-
velopment of leukemia. Mice receiving cells ex-
pressing Nic alone became moribund with leuke-
mia with a mean latency of 64 days, while mice
receiving cells expressing both Ik-6 and Nic suc-
cumb to leukemia with a mean latency of 24
days. Mice that received cells expressing neither
Nic nor Ik-6 did not develop any signs of disease
during the course of the experiment.
Discussion A simple explanation for this observation is that transcription is
being initiated from the proviral LTR, resulting in Ik message
that does not contain sequences derived from exon 1 or 2 and,In this report, we provide evidence that loss of Ik DNA binding
activity is a common step in the progression of Nic-induced therefore, would not be amplified by the PCR primers used. To
address this issue, we performed rt-PCR analysis using primersT cell leukemia. Consistent with current multistep models for
tumorigenesis, Nic transgenic mice succumb to T cell leukemia located in the LTR of the provirus and combinations of primers
in the Ik gene. However, no hybrid messages were detected.after a lengthened latency, suggesting that other genetic muta-
tions must accumulate in these mice in order for leukemia to Furthermore, we did not detect any Ik proteins in these tumor
samples by Western blot analysis. The Ik antibody that we useddevelop. By using proviral insertional mutagenesis as a genetic
tool to introduce somatic mutations in Nic transgenic mice, the recognizes residues encoded by exon 7 that are essential for
heterodimerization and are found in all DI Isoforms. Since weonset of leukemia was greatly accelerated. Since integration of
the provirus is a random event, common sites of integration did not detect any isoforms in these samples, we conclude that
in these tumors, the effect of proviral integration is the loss offound among different leukemia samples likely represent a
gene(s) that, when disrupted by the provirus, cooperates with Ik-1/2 expression. In support of our observations, it was recently
reported that loss of Ik activity correlates with progression ofthe transgene to accelerate leukemogenesis. Here we identify
that the Ik gene is a common target of proviral integration in chronic mylogenous leukemia from the chronic phase of the
disease to blast crisis (Nakayama et al., 1999). In this study,Nic transgenic mice (Figure 1D).
We demonstrated that MLV specifically integrates into a 50 the Ik expression status was determined by rt-PCR and Western
blot analysis in a small set of patients that were either in chronickb intron in the Ik gene in Nic transgenic mice. Integration into
this locus effects Ik expression in two different manners: either phase or blast crisis. Patients in the chronic phase of the disease
had normal Ik expression patterns. In contrast, a majority ofthe normal process of isoform selection is skewed, such that
there is an increase in expression of dominant inhibitory (DI) patients in blast crisis had altered Ik expression. Similar to the
observations reported herein, there were essentially two effectsisoforms, or there is a dramatic loss in detectable message
encoding DNA binding Ik isoforms (Figures 2B and 2C). We on Ik expression, either a loss of Ik-1/2 mRNA expression or
overexpression of DI isoforms. Therefore, we conclude that thecloned Ik mRNAs from tumors that expressed DI isoforms and
identified a number of previously characterized DI Ik isoforms, effect of proviral integration into the 50 kb intron separating
exons 2 and 3 results in the perturbation of normal Ik expressionas well as isoforms that we termed leukemia associated iso-
forms (LAI). All these isoforms lack the critical DNA binding zinc and regulation of isoform selection. Interestingly, Southern blot
analysis of the DNA derived from the blast crisis patients indi-finger motifs encoded by exon four, and we demonstrated that
they could not bind DNA in vitro by EMSA analysis (Figure 4C). cated that there might be small deletions and/or insertions in
the Ik locus. These mutations were not finely mapped withinThe other N/MLV tumors that had integrations into the Ik locus
displayed a loss of Ik-1/2 expression when analyzed by rt-PCR. the locus; however, our prediction is that these mutations are
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Figure 8. Reduced transcriptional repression by
Ik cooperates with Nic to accelerate T cell leuke-
mogenesis
A: Regulation of genes during proliferation/dif-
ferentiation is a tightly coordinated process. See
text for details.
B: Leukemic conversion in Nic transgenic mice
through loss of Ik repressor activity. See text for
details.
likely located in a similar location, as we have described for Ik isoforms are expressed through alternative splicing (Hahm et
al., 1994; Molnar and Georgopoulos, 1994). This would resultproviral integration. Furthermore, we suggest that sequences
in the intron located near the site of integration might play a in the removal of Ik1/2 from the regulatory element, and this
unoccupied Ik/CSL site can then be bound by CSL (Figure 8A,vital role in regulating isoform selection.
What is the biochemical basis for cooperation between II). However, in the absence of activated Notch, CSL will recruit
additional corepressors (Co-R) and keep the gene in a repressedNotch and Ik in leukemogenesis? We have provided compelling
evidence that indicates that cooperation is due to derepression state (Honjo, 1996; Hsieh et al., 1999; Kao et al., 1998; Zhou et
al., 2000; Zhou and Hayward, 2001). Following ligand activation,of Ik-regulated genes that can consequently be activated by
the Notch pathway. The first piece of data that led us to this Notch translocates to the nucleus and converts the CSL repres-
sor complex into an activator complex by displacing the Co-Rmodel of cooperation is that Ik and the Notch effector protein,
CSL, are capable of binding the same core DNA consensus with coactivators (Co-A) (Figure 8A, III) (Jeffries et al., 2002;
Kitagawa et al., 2001; Oswald et al., 2001; Wallberg et al., 2002;sequence, TGGGAA (Figure 4). We reasoned that if Ik is a repres-
sor of transcription and can bind to the same regulatory element Wu et al., 2002). Therefore, the transition from scenario I to II
would maintain the repressive state of the gene until instructiveas CSL, then Ik expression might block Nic activation of the
reporter. Investigating the consequence of Ik expression on Nic- signaling, i.e., activation of Notch in this case.
It is not currently clear what signals control Ik isoform selec-induced CSL-dependent transcriptional activation, we found
that this was the case. Coexpression of Ik in the Nic reporter tion during development, nor is it clear if under physiological
conditions Ik can ever be converted into an activator of tran-assay resulted in a dose-dependent decrease in reporter activity
(Figure 5A). Furthermore, the DI isoform Ik-6 was able to relieve scription by a mechanism other than sequestration by DI iso-
forms. For example, mature hematopoietic cells do not expressthis repression in a dose-dependent manner (Figure 5B). These
results demonstrate that the loss of Ik DNA binding activity, DI Ik isoforms, indicating that Ik-regulated genes are terminally
silenced. However, it is clear that maintaining Ik activity andeither by reduced expression of DNA binding isoforms or over-
expression of DI isoforms, can have dramatic effects on tran- silencing certain genes is very important, since aberrant expres-
sion of DI isoforms leads to leukemia in mice and humans (Na-scription of Nic/CSL regulated genes.
In Figure 8 we illustrate a model of a gene that can be kayama et al., 1999; Sun et al., 1999a; Winandy et al., 1995).
Recently, the Smale group provided evidence that demon-regulated by both Ik and CSL through a common regulatory
element. Under physiological conditions there is likely a dynamic strates that Ik and the Ets family member Elf-1 directly compete
for DNA binding sites on the TDT promoter (Trinh et al., 2001).balance between scenarios I, II, and III, depending on the devel-
opmental stage of the cell. Ik is thought to silence gene expres- Following stimulation of double positive T cells, Ik displaces the
activator protein Elf-1 at a specific site in the TDT promoter tosion through chromatin remodeling and localization of genes to
regions of heterochromatin (Cobb et al., 2000; Kim et al., 1999; repress transcription. Downregulation of TDT expression was
also correlated with localization of the gene to pericentrimericKoipally and Georgopoulos, 2000, 2002; Trinh et al., 2001). How
would this gene become activated if transcriptionally silenced chromatin, indicating that Ik rendered the TDT gene transcrip-
tionally silent. In the developing Drosophila eye, Pointed (pnt)by Ik? During certain stages of hematopoietic development, DI
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blocks Notch-dependent induction of yan expression by blocking apoptotic pathway induced by myc through inhibition of INK4a/
ARF expression, indicating that myc-induced tumorigenesis re-access of su(H), the Drosophila homolog of CSL, to a regulatory
element by binding to an overlapping regulatory element (Rohr- quires additional genetic mutations that are able to inhibit apo-
ptotic functions (Jacobs et al., 1999). Interestingly, Notch hasbaugh et al., 2002). Therefore, pnt and su(H) compete for a
binding site in the enhancer of yan, such that pnt occupation been demonstrated to play a role in inhibition of apoptosis by
interaction with Nur-77, suggesting that the need for activationof the sequences inhibits Notch signaling from activating tran-
scription of the gene. pnt is a component of the receptor tyrosine of Notch in MMTV(D)-myc induced leukemogenesis is for the
inhibition of apoptosis (Jehn et al., 1999). In contrast, both Notchkinase (RTK) signaling cascade and provides a means by which
RTK signaling can directly oppose the effects of Notch signaling. and c-myc directly upregulate components of the cell cycle and
drive proliferation, independent of growth signals (Bouchard etThese examples clearly demonstrate that multiple transcription
factors can coordinate the regulation of specific genes through al., 1999; Hermeking et al., 2000; Mateyak et al., 1999; Ronchini
and Capobianco, 2001). Therefore, there might not be a selec-common regulatory elements regulating processes such as dif-
ferentiation and proliferation during development. tive advantage to overexpress c-myc in Nic-induced leukemia.
What is the selective advantage gained by disruption of Ik ex-We propose that the transition from a normal (or preneoplas-
tic) cell to a leukemic cell in Nic transgenic mice occurs through pression for Nic induced leukemogenesis? At this point, it is not
clear what cellular processes might be subverted by loss ofthe loss of Ik DNA binding activity either by decreasing expres-
sion of Ik1/2 or skewing isoform selection toward DI Ik isoforms Ik repressor activity. However, it appears that cooperation is
occurring, at least in part, by making Notch a better oncogene by(Figure 8B). This event leads to Ik/CSL-regulated genes that
were previously occupied by Ik to become unoccupied and providing access to previously unavailable regulatory elements.
therefore bound by CSL/Nic, resulting in constitutive unregulated Future studies should provide a physiological basis for this co-
activation of this subset of genes. Since there are regulatory operation.
elements that are Ik- and CSL-specific, how do we know that
Experimental proceduresit is the Ik/CSL-regulated genes that are important for leukemo-
genesis? Two lines of evidence indicate that this might be the
Detailed experimental procedures will be provided upon request and can
case. The first is that the Molt3 cell line, which has mutant Ik be found in the Supplemental Data at http://www.cancercell.org/cgi/content/
isoforms, also has constitutively active Nic. The second line of full/3/6/551/DC1.
evidence is that integration of MLV into the Ik locus was not a
Nic transgenic mice and MLV infectionsselective advantage in general, since we observed no integra-
The lck-Nic transgenic mouse line was obtained from Ellen Robey and hastions into the locus unless we used the Nic transgenic back-
been previously described (Robey et al., 1996). Proviral insertional mutagen-ground. Although this evidence is compelling, we cannot rule
esis was performed by intraperitoneal injection of neonatal mice with viralout the possibility that specific Ik regulated genes that are not
supernatants containing MoMLV.
regulated by CSL are contributing to the process of leukemo-
genesis. Southern blot analysis
What drives the selective process for additional mutations Southern blot analysis was performed using standard techniques.
in leukemogenesis? In a recent review, Hanahan and Weinberg
Isolation of proviral integration tags (pvits)suggest that the driving force for the selection of multiple muta-
High molecular weight genomic DNA (2 g) was digested overnight at 65	Ctions in tumorigenesis is the acquisition of mutations that sub-
using the restriction enzyme TaqI (NEBL). DNA was circularized by ligationvert six distinct physiological processes, including dependence
at a final concentration of 1 ng/l using T4 DNA ligase (NEBL). 5 ng of
on proliferative signals and evasion of apoptosis (Hanahan and recircularized DNA was subjected to two rounds of inverse PCR (IPCR) using
Weinberg, 2000). Several recent studies have demonstrated AGS gold taq polymerase (Hybaid). Following the second round of PCR,
that the Notch locus is a common target of proviral integration IPCR products were ligated directly into the PCR2.1 TA vector system (In-
vitrogen) using the manufacturer’s recommended protocol.(Feldman et al., 2000; Girard et al., 1996; Hoemann et al., 2000;
Kim et al., 2003; Lund et al., 2002; Mikkers et al., 2002). In fact,
RT-PCR analysisin MMTV(D)/myc transgenic mice, the Notch locus is targeted
RNA was extracted from tumor samples using Trizol (Gibco) following thein more that 50% of accelerated leukemias, indicating that muta-
manufacturer’s protocol. Total RNA (2 g) was used to produce cDNA in a
tion of Notch is an important event in c-myc induced leukemo- 20 l reaction using MLV reverse transcriptase (Promega) according to
genesis (Girard et al., 1996). Intuitively, one would assume that manufacturer’s specifications.
in Notch-induced leukemia, disruption of c-myc might also be
Protein analysisa common event. For example, pim-1 is targeted by MLV inte-
Frozen tumor samples were pulverized in liquid nitrogen using a mortar andgration in 35% of E-myc-induced lymphomas, whereas myc
pestle. Proteins extracts were prepared by lysis of cells in standard lysis(c- or n-myc) is targeted by MLV integration in more that 90%
buffer followed by standard immunoblotting techniques. Subcellular fraction-
of E-pim-1 induced lymphomas (van Lohuizen et al., 1989, ation, size exclusion chromatography, TCA precipitations, and immunopre-
1991). However, we demonstrated that reciprocal cooperation cipitations were performed as previously described, with the exceptions
between two genes is not necessarily the rule, since we ob- noted in the Supplemental Data.
served that the c-myc locus is not commonly disrupted in Nic
Luciferase reporter gene assaytransgenic mice. This suggests that the initiating oncogenic
Luciferase reporter gene assays were performed as previously describedevent might dictate the need for subsequent mutations. For
(Jeffries and Capobianco, 2000).example, Bmi-1 was originally identified as a common target of
proviral integration in 35% of E-myc induced lymphomas (van Plasmid constructs and expression analysis
Lohuizen et al., 1991). It has since been demonstrated that Ik cDNAs were cloned from RT-PCR reactions (described above). Briefly,
cDNA was amplified for 30 cycles using Ik-specific primers and cDNAs wereBmi-1 overexpression cooperates with c-myc by inhibiting the
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of cyclin D2 by Myc contributes to cell cycle progression and sequestrationpurified using Qiagen quick spin column. cDNA was then digested using
of p27. EMBO J. 18, 5321–5333.EcoRI and XhoI (NEBL) and ligated into pcDNA3.1 (Invitrogen) and pGEX-
4T1 (Pharmacia). Cloned PCR products were verified by sequencing. Bray, S., and Furriols, M. (2001). Notch pathway: making sense of suppressor
of hairless. Curr. Biol. 11, R217–R221.
Electrophoretic mobility shift assays
Cobb, B.S., Morales-Alcelay, S., Kleiger, G., Brown, K.E., Fisher, A.G., andGST fusion proteins were produced in E. coli. GST fusion proteins were
Smale, S.T. (2000). Targeting of Ik to pericentromeric heterochromatin bypurified by glutathione-agarose beads. 60 fmol of double-stranded oligo
direct DNA binding. Genes Dev. 14, 2146–2160.were labeled with 50 Ci of [
-32P]ATP using T4 polynucleotide kinase
(NEBL). [32P]-labeled oligos were purified through Sephadex G-50 spin col- Codias, E.K., Olosz, F., and Malek, T.R. (2000). Genomic organization and
umn. DNA binding reactions were performed in HGED buffer with 0.6 fmol 5 regulatory region of the mouse IL-2 receptor -chain gene (IL-2Rb). Immu-
of probe and approximately 10 ng of GST protein at room temp for 30 nogenetics 51, 508–512.
min. DNA/protein complexes were separated on 4% polyacrylamide gel
Deftos, M.L., and Bevan, M.J. (2000). Notch signaling in T cell development.containing 5% glycerol in 1 TGE.
Curr. Opin. Immunol. 12, 166–172.
Deftos, M.L., Huang, E., Ojala, E.W., Forbush, K.A., and Bevan, M.J. (2000).Bone marrow reconstitution assays
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes.Mice transgenic for a tetracycline operator Nic were injected i.p. with 150
Immunity 13, 73–84.g of 5-flourouracil. Two days following treatment, the bone marrow cells
(BM) from these mice were harvested using standard procedures. Red blood DiFronzo, N.L., Leung, C.T., Mammel, M.K., Georgopoulos, K., Taylor, B.J.,
cells were lysed in RBC lysis buffer (150 mM NH4Cl, 10 mM KHCO3, and and Pham, Q.N. (2002). Ik, a lymphoid-cell-specific transcription factor, con-
10 M EDTA). Cells were spinfected with the described viruses in the pres- tributes to the leukemogenic phenotype of a mink cell focus-inducing murine
ence of 24 g of polybrene. Spinfections were carried out at 3100 rpm leukemia virus. J. Virol. 76, 78–87.
at 30	C for 2.5 hr in a Sorvall RT7 swinging bucket centrifuge. Following
Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T.C., Smith, S.D.,spinfection, BM was resuspended in complete media and incubated for 30
and Sklar, J. (1991). TAN-1, the human homolog of the Drosophila notchmin at 37	C. Transduced BM was used to reconstitute syngeneic FVB/n
gene, is broken by chromosomal translocations in T lymphoblastic neo-mice that had been lethally irradiated with 1100 rads given in two separate
plasms. Cell 66, 649–661.
550 rad doses four hours apart.
Feldman, B.J., Hampton, T., and Cleary, M.L. (2000). A carboxy-terminal
deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A–PBX1Acknowledgments
transgenic mice. Blood 96, 1906–1913.
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